U.S. flag

An official website of the United States government

NM_006796.3(AFG3L2):c.2011G>A (p.Gly671Arg) AND Spinocerebellar ataxia type 28

Germline classification:
Pathogenic (3 submissions)
Last evaluated:
Jul 18, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000023378.8

Allele description [Variation Report for NM_006796.3(AFG3L2):c.2011G>A (p.Gly671Arg)]

NM_006796.3(AFG3L2):c.2011G>A (p.Gly671Arg)

Gene:
AFG3L2:AFG3 like matrix AAA peptidase subunit 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
18p11.21
Genomic location:
Preferred name:
NM_006796.3(AFG3L2):c.2011G>A (p.Gly671Arg)
HGVS:
  • NC_000018.10:g.12337505C>T
  • NG_023361.1:g.44772G>A
  • NM_006796.3:c.2011G>AMANE SELECT
  • NP_006787.2:p.Gly671Arg
  • NP_006787.2:p.Gly671Arg
  • LRG_666t1:c.2011G>A
  • LRG_666:g.44772G>A
  • LRG_666p1:p.Gly671Arg
  • NC_000018.9:g.12337504C>T
  • NM_006796.2:c.2011G>A
  • Q9Y4W6:p.Gly671Arg
  • p.G671R
Protein change:
G671R; GLY671ARG
Links:
UniProtKB: Q9Y4W6#VAR_064407; OMIM: 604581.0008; dbSNP: rs151344517
NCBI 1000 Genomes Browser:
rs151344517
Molecular consequence:
  • NM_006796.3:c.2011G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Spinocerebellar ataxia type 28 (SCA28)
Identifiers:
MONDO: MONDO:0012450; MedGen: C1853249; Orphanet: 101109; OMIM: 610246

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000044669OMIM
no assertion criteria provided
Pathogenic
(Oct 1, 2010)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV000054613GeneReviews
no classification provided
not providedgermlineliterature only

SCV000746662Undiagnosed Diseases Network, NIH - Undiagnosed Diseases Network (NIH), UDN
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jul 18, 2017)
unknownclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedliterature only
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
Whiteunknownyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Missense mutations in the AFG3L2 proteolytic domain account for ∼1.5% of European autosomal dominant cerebellar ataxias.

Cagnoli C, Stevanin G, Brussino A, Barberis M, Mancini C, Margolis RL, Holmes SE, Nobili M, Forlani S, Padovan S, Pappi P, Zaros C, Leber I, Ribai P, Pugliese L, Assalto C, Brice A, Migone N, Dürr A, Brusco A.

Hum Mutat. 2010 Oct;31(10):1117-24. doi: 10.1002/humu.21342.

PubMed [citation]
PMID:
20725928

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From OMIM, SCV000044669.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In affected members of 2 unrelated families with autosomal dominant spinocerebellar ataxia-28 (SCA28; 610246), Cagnoli et al. (2010) identified a heterozygous 2011G-A transition in exon 16 of the AFG3L2 gene, resulting in a gly671-to-arg (G671R) substitution in a highly conserved residue in the C-terminal proteolytic peptidase-M41 domain. Haplotype analysis indicated a founder effect. Gly671 is located on the surface of the AFG3L2 complex, and the mutation was predicted to decrease the electrostatic potential difference between the inner mitochondrial membrane side and the matrix side of the hexameric complex, as well as decrease the central pore dipole. These findings suggested a destabilizing effect. The mutation was not identified in 380 French or Italian control chromosomes.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From GeneReviews, SCV000054613.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature onlynot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Undiagnosed Diseases Network, NIH - Undiagnosed Diseases Network (NIH), UDN, SCV000746662.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1White1not providednot providedclinical testing
(GTR000553916.1)
PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot provided
(GTR000553916.1)
1not providednot providednot provided

Last Updated: Oct 1, 2022